Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response
Author(s): Briggs Valerie
Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue
Page(s): 366-369
Download in electronic PDF format for $75
Abstract: In response to growing concerns regarding the improper disposal of prescription and over-the-counter drugs and its impact on the environment and teen drug abuse, the National Community Pharmacists Association developed a Prescription Disposal Program to assist its members in voluntarily developing consumer disposal options in their stores. The program includes a discount on products from partner organization Sharps Compliance Inc., free marketing materials, and national promotion via a new consumer website. To date, the program has nearly 1,000 community pharmacies in 47 states participating. A collection of 8,000 pounds of drugs has resulted, with more campaigns slated for the future. Included with this article are testimonials from compounding pharmacists who have initiated National Community Pharmacists Association’s drug disposal program.
Related Keywords:
Valerie Briggs, MBA, environmental safety, drug disposal, National Community Pharmacists Association, consumer education
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response
Briggs Valerie
|
Sep/Oct 2010
Pg. 366-369
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
|
Jan/Feb 2008
Pg. 87
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020
Pg. 451-458
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
|
Mar/Apr 2022
Pg. 100-109
|
PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future
Huffman D C
|
Jul/Aug 2010
Pg. 350-351
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives
Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo
|
Mar/Apr 2016
Pg. 114-122
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Standard Operating Procedure: Disposal of Chemicals
Allen Loyd V Jr
|
May/Jun 2004
Pg. 210
|
PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 268
|
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH, Mixon William, Allan W Chris
|
Sep/Oct 2020
Pg. 371-379
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
|
Jan/Feb 2008
Pg. 38-47
View Sample |
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy
Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle
|
Mar/Apr 2014
Pg. 159-161
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
| Return to Top |
